Table 1.
Patient characteristics
| Parameter | Number | Percent | |
|---|---|---|---|
| Median Age, IQR | 58, 52.5–66 | ||
| Sex | |||
| Female | 2 | 8 | |
| Male | 22 | 92 | |
| Site | |||
| Base of tongue | 15 | 63 | |
| Tonsil | 4 | 17 | |
| Supraglottic larynx | 1 | 4 | |
| Nasopharynx | 2 | 8 | |
| Oral cavity | 1 | 4 | |
| Unknown primary | 1 | 4 | |
| HPV Status | |||
| Positive | 20 | 83 | |
| Negative | 2 | 8 | |
| Not applicable/Unknown | 2 | 8 | |
| Smoking | |||
| < 10 pack-years | 13 | 54 | |
| > 10 pack-years | 11 | 46 | |
| Concurrent chemotherapy | |||
| Bolus cisplatin | 11 | 46 | |
| Weekly cisplatin | 8 | 33 | |
| Carboplatin-Taxol | 2 | 8 | |
| No chemotherapy | 3 | 13 | |
| T-stage | |||
| Tx | 1 | 4 | |
| T1 | 8 | 33 | |
| T2 | 7 | 29 | |
| T3 | 5 | 21 | |
| T4 | 3 | 13 | |
| N-stage | |||
| N0 | 5 | 21 | |
| N1 | 4 | 17 | |
| N2a | 3 | 13 | |
| N2b | 10 | 42 | |
| N2c | 2 | 8 | |
| Stage | |||
| I | 2 | 8 | |
| II | 2 | 8 | |
| III | 3 | 13 | |
| IV | 17 | 71 | |